Harvard T.H. Chan School of Public Health

Harvard T.H. Chan School of Public Health

Consultation date: 25 August 2017

Malaria elimination strategy

Defeating Malaria: From the Genes to the Globe Initiative 

Harvard University’s involvement in malaria dates back to the Harvard Expedition of the 1920s where malaria was documented and studied in Liberia and the Belgian Congo. In the 1940s, Harvard chemists worked on the chemical synthesis of quinine, the first antimalarial drug. More recently, individual faculty across the University have focused on advancing biomedical research and leading research efforts on the economic and cultural impact of malaria.

In 2013, Harvard University launched Defeating Malaria: From the Genes to the Globe, a cross-university initiative to produce, transmit, and translate knowledge to support the control and eradication of malaria. This initiative is spearheaded by the Harvard T.H. Chan School of Public Health, in collaboration with the Harvard Global Health Institute and in partnership with the United Nations Secretary-General’s Special Envoy for Health in Agenda 2030 and for Malaria. Harvard’s Defeating Malaria Initiative provides an opportunity to have a distinctive impact on malaria by attracting the breadth and depth of expertise necessary for sustained, multidisciplinary collaborations and establishing new types of external partnerships to end malaria.

Defeating Malaria

Leading 50 project(s)

Feb 2012 to Dec 2014

Identifying a laboratory marker of artemisinin resistance

Jan 2009 to Aug 2013

Research capacity for the implementation of genetic control of mosquitoes (INFRAVEC)


Partnering on 37 project(s)

Jul 2010 to Jun 2016

Epidemiology of malaria (West Africa ICEMR)

Jan 2013 to Jun 2017

Pilot phase for the MAL067 RTS,S immunology ancillary study